TranspariMED clinical trial transparency

22 Aug 2019

With the conclusion of 72nd World Health Assembly (WHA), governments reiterated their support for transparency in medicines research and development.

Indirectly, at centre stage of the assembly, was clinical trials where governments debated the “transparency clause”. This would mean that companies would have to disclose the actual costs of researching and manufacturing of medic...

Please reload

Recent Posts
Please reload

This site was designed with the
website builder. Create your website today.
Start Now